Alnylam's gene silencing drug wins FDA approval

Alnylam Pharmaceuticals Inc's drug for a rare hereditary disease won U.S. regulatory approval on Friday, becoming the first approved treatment from a new class of medicines that use gene silencing technology.

from Reuters: Health https://ift.tt/2nqLIul
via IFTTT

• Tweet
• Share
• Share
• Share
• Share